Table 1.
Simulated treatments and the expected final LDL-c, according to strategies and baseline LDL-c
| Strategy | Baseline LDL-c | Treatment | Final LDL-c |
|---|---|---|---|
| S30% | |||
| ≥ 70 mg/dL | 30% LDL-c reduction | = baseline LDL-c – 30% | |
| S50% | |||
| ≥ 70 mg/dL | 50% LDL-c reduction | = baseline LDL-c – 50% | |
| Starget-100 | |||
| ≥ 120 mg/dL | ≥ 30% LDL-c reduction | = baseline LDL-c – 30% or 100 mg/dL (2.6 mmol/L)* | |
| Starget-70 | |||
| ≥84 mg/dL | ≥ 30% LDL-c reduction | = baseline LDL-c – 30% or 70 mg/dL (1.8 mmol/L)* |
The lower value was considered.